In its second year, QSP Day is a full day event featuring talks from key industry and academic researchers, a poster session with awards, and networking time with peers.

All registrants are welcome to submit posters in either student or non-student categories. Three abstracts will be invited to give a 15-minute presentation during the conference. In addition, cash prizes will be awarded to the top three student posters, with first place receiving $1,000, second place receiving $500, and third place receiving $200. 

Agenda

9:00 AM - Registration and breakfast

9:30 AM - Opening Remarks | John Burke, PhD, Applied BioMath

9:45 AM - Keynote Presentation | Douglas A. Lauffenburger, PhD, MIT

10:30 AM - Break and poster viewing session 

11:00 AM - Presentation | Rupert Davies, PhD, Zymeworks

11:45 AM - Lunch and poster viewing session 

1:00 PM - Presentation | Haiqing Wang, PhD, Bristol-Myers Squibb

1:45 PM - Three invited lightning talks from poster abstracts

2:30 PM - Break and poster viewing session 

3:00 PM - Presentation | Alison Betts, PhD, Pfizer

3:45 PM - Poster awards and closing remarks

4:15 PM - Social hour and networking

5:00 PM - Symposium adjourns

Featured Speakers

  Douglas A. Lauffenburger, PhD                                                                       

 Ford Professor of Biological Engineering, Chemical Engineering and Biology     Head of the Department of Biological Engineering                           Massachusetts Institute of Technology                                                     

 Title: Computational Analysis of Tumor Heterogeneity toward Determination                                         of Combinatorial Drug Treatment

 Haiqing Wang, PhD                        

 Principal Scientist                                                                                           Bristol-Myers Squibb                                                                                   

 Title: Integrating Nonclinical PK/PD Data for Novel Cancer Immune     Therapeutics First-in-Human Starting Dose Selection

 

 Rupert Davies, PhD                        

 Principal Scientist, Oncology                                                                 Zymeworks                                                                                                 

 Title: Utilizing QSP Modeling to Drive Clinical and Nonclinical Development of   Zymeworks’ Biparatopic Azymetric Platform

 

 Alison Betts, PhD                     

 Associate Research Fellow                                                                                                           Pfizer                                                                                 

Title: Use of Modeling & Simulation to compare Pfizer’s new generation HER2 ADC (PF-06804103) with KadcylaTM: a focus on PK and efficacy

Photos From QSP Day 2017